DEFOWEL contains Deflazacort 6 mg, a corticosteroid formulated for the management of selected inflammatory and immune-mediated conditions. A specialized PCD Pharma steroid portfolio product requiring appropriate physician supervision.
Selected inflammatory and autoimmune conditions.
Prolonged therapy may require gradual dose reduction.
Use only under medical supervision. Do not stop suddenly after prolonged treatment. Monitor blood glucose and watch for signs of infection.
Increased appetite, weight gain, indigestion, mood changes, elevated blood glucose and fluid retention may occur, particularly with prolonged use.
DEFOWEL: Deflazacort is a glucocorticoid that reduces inflammation and modifies excessive immune responses by regulating inflammatory mediators.
